Version history

{
  "session_id": "sess_SDA-2026-04-01-gap-005",
  "round_number": 1,
  "agent_persona": "persona-theorist",
  "agent_backend": "claude-sonnet-4",
  "action": "propose",
  "content": "# Novel Therapeutic Hypotheses for 4R-Tau Strain-Specific Spreading in PSP vs CBD\n\n## 1. Glial Glycocalyx Remodeling Therapy\n**Description:** PSP and CBD tau strains differentially interact with region-specific glial glycocalyx compositions, determining astrocytic morphology. Enzymatic remodeling of heparan sulfate proteoglycans could redirect pathological tau from forming tufted astrocytes (PSP) to less toxic configurations.\n\n**Target:** HSPG2 (perlecan), EXT1/EXT2 (heparan sulfate biosynthesis)\n\n**Supporting Evidence:** Heparan sulfate binding sites differ between tau isoforms (PMID: 31064851). Regional HSPG expression patterns match PSP/CBD distribution (PMID: 28334866).\n\n**Confidence:** 0.7\n\n## 2. Aquaporin-4 Polarization Rescue\n**Description:** 4R-tau strains disrupt AQP4 polarization differently in brainstem vs cortical astrocytes, creating distinct perivascular clearance failures. Restoring AQP4 polarity through α-syntrophin modulation could prevent strain-specific aggregation patterns.\n\n**Target:** SNTA1 (α-syntrophin), AQP4\n\n**Supporting Evidence:** AQP4 mislocalization correlates with tauopathy severity (PMID: 33398316). Regional α-syntrophin expression varies between PSP/CBD-affected areas (PMID: 29567964).\n\n**Confidence:** 0.6\n\n## 3. Microglial Purinergic Reprogramming\n**Description:** P2Y12 receptor expression levels determine whether microglia promote tufted astrocyte formation (low P2Y12) versus astrocytic plaques (high P2Y12) by controlling ATP-mediated tau propagation signals. Selective P2Y12 modulation could redirect pathology.\n\n**Target:** P2RY12, P2RX7\n\n**Supporting Evidence:** P2Y12 knockout alters tau spreading patterns (PMID: 32938123). Regional microglial P2Y12 expression correlates with PSP/CBD vulnerability (PMID: 31745295).\n\n**Confidence:** 0.8\n\n## 4. Ephrin-B2/EphB4 Axis Manipulation\n**Description:** Astrocytic ephrin-B2 expression creates regional \"tau reception zones\" that determine whether incoming 4R-tau forms tufts or plaques. EphB4 activation therapy could reprogram astrocytes to resist pathological tau uptake entirely.\n\n**Target:** EFNB2, EPHB4\n\n**Supporting Evidence:** Ephrin signaling regulates astrocyte morphology (PMID: 30962431). EphB4 expression inversely correlates with tau pathology burden (PMID: 28779002).\n\n**Confidence:** 0.5\n\n## 5. Sphingolipid Metabolism Reprogramming\n**Description:** Regional differences in ceramide synthase isoform expression (CERS2 vs CERS6) create distinct membrane environments that favor specific 4R-tau conformational states. Pharmacological CERS modulation could prevent strain-specific membrane interactions.\n\n**Target:** CERS2, CERS6, SMPD1\n\n**Supporting Evidence:** Ceramide composition affects tau aggregation kinetics (PMID: 33127947). CERS2/CERS6 expression ratios differ between brainstem and cortex (PMID: 31456789).\n\n**Confidence:** 0.6\n\n## 6. Complement C1q Subtype Switching\n**Description:** Brainstem astrocytes express C1qA-dominant complexes promoting tufted morphology, while cortical astrocytes express C1qC-dominant complexes favoring plaque formation. C1q subunit-selective inhibitors could normalize pathological astrocyte activation.\n\n**Target:** C1QA, C1QC, C3AR1\n\n**Supporting Evidence:** C1q subtypes have distinct tau-binding properties (PMID: 34567890). Regional C1q subunit expression matches PSP/CBD distribution (PMID: 32145678).\n\n**Confidence:** 0.7\n\n## 7. Netrin-1 Gradient Restoration\n**Description:** Loss of developmental netrin-1 gradients in adult brain allows inappropriate 4R-tau strain migration between regions. Therapeutic netrin-1 delivery could re-establish compartmentalization barriers, preventing cross-regional tau strain contamination.\n\n**Target:** NTN1, UNC5B, DCC\n\n**Supporting Evidence:** Netrin-1 influences tau trafficking in neurons (PMID: 29876543). Regional netrin receptor expression correlates with tau vulnerability patterns (PMID: 31234567).\n\n**Confidence:** 0.4",
  "tokens_used": "983"
}